Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
A0001 in Friedreich's Ataxia
NCT01035671Phase 2Completed
- Sponsor
- Penwest Pharmaceuticals Co.
- Start
- Dec 2009
- Primary completion
- Feb 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of alpha-tocopherolquinone in Friedreich ataxia (FA), sponsored by Penwest Pharmaceuticals Co.. Started Dec 2009; status: completed.
02
Drugs
alpha-tocopherolquinone
03
Conditions
Friedreich ataxia (FA)
Beyond the preview
Go deeper on NCT01035671.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01035671.